TOPIC
bharat biotech
WHO finally approves Bharat Biotech’s Covid-19 vaccine Covaxin, grants it Emergency Use Listing status
WHO granted Emergency Use Listing status to Covaxin after the Technical Advisory Group of WHO recommended the same earlier today
Australia recognises Bharat Biotech’s Covaxin for travellers visiting the country
Australia has approved Bharat Biotech's Covid-19 vaccine Covaxin to establish a traveller's vaccination status
Gujarat gets into mission mode: Ankleshwar plant for Bharat Biotech releases first batch of Covaxin vaccine within two weeks of approval
Bharat Biotech had said that IIL's Ankleshwar-based production facility would add another 200 million doses to its overall vaccine production.
How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy
NDTV's Sreenivasan Jain doesn't let facts get into the way of mischief that could create vaccine hesitancy and derail India's vaccination programme
As Congress party allies with left parties in Brazil to claim a ‘scam’ in Covaxin deal, here is how the allegations are baseless
Opposition in Brazil forced the govt to cancel Covaxin purchase deal wrongly claiming that it was overpriced and there were irregularities in it
Bharat Biotech releases Phase-3 trials data of Covaxin: Indian-made vaccine 77.8% effective against mild cases, 93% against severe cases
Bharat Biotech announced efficacy analysis data from Phase-3 clinical trials of Covaxin, proved to be highly effective against severe cases of COVID-19
Congress leader spreads vaccine hesitancy again, this time claims newborn calves are slaughtered for their serum. Here is the truth
Anurag -
Covaxin does not contain newborn calf serum. It was used for development of cells to replicate Covid-19 virus in lab to produce vaccine.
US FDA rejects emergency use application for Bharat Biotech’s Covaxin, asks Ocugen to launch additional trial for full approval
The US FDA had asked Ocugen to pursue BLA submission and not Emergency Use Approval(EUA), paving the way for the vaccine's full approval in the United States.
Maharashtra wants Bharat Biotech to set aside 50% vaccines manufactured at the proposed Pune plant for itself: Report
Deputy CM Ajit Pawar said that he would request Bharat Biotech to reserve 50% of the vaccines manufactured at the proposed Pune plant for distribution within the state
Bharat Biotech welcomes other pharma companies to manufacture Covaxin, but only one other Indian company has the required facility
Only 2 Indian companies have BSL3 level plants to produce Covaxin made from inactivated virus, Bharat Biotech and Panacea Biotec
